Lucid Diagnostics Inc. - Common Stock, par value $0.001 per share (LUCD)

Historical Holders from Q4 2021 to Q3 2025

Symbol
LUCD on Nasdaq
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
137M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
35.1M
Holdings value
$35.5M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
83
Number of buys
52
Number of sells
-21
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Lucid Diagnostics Inc. - Common Stock, par value $0.001 per share (LUCD)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PAVmed Inc. 28.3% $39.2M 38.8M PAVmed Inc. 09 Oct 2025
Ayrton Capital LLC 2% $1.6M 1.2M Ayrton Capital LLC 31 Dec 2024

Institutional Holders of Lucid Diagnostics Inc. - Common Stock, par value $0.001 per share (LUCD)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 35.1M $35.5M +$16.3M $1.01 83
2025 Q2 18.9M $21.7M +$10.8M $1.15 70
2025 Q1 9.36M $13.9M +$9.08M $1.49 47
2024 Q4 3.3M $2.7M +$682K $0.82 31
2024 Q3 2.45M $2M +$374K $0.82 27
2024 Q2 1.99M $1.64M -$60.9K $0.82 31
2024 Q1 2.07M $1.69M +$173K $0.81 26
2023 Q4 1.75M $2.46M -$132K $1.41 23
2023 Q3 1.92M $2.24M +$59.7K $1.17 23
2023 Q2 1.86M $2.59M +$132K $1.39 16
2023 Q1 1.77M $2.49M -$200K $1.40 18
2022 Q4 1.91M $2.6M -$580K $1.36 21
2022 Q3 2.3M $3.52M -$264K $1.53 20
2022 Q2 2.46M $5.55M -$914K $2.26 23
2022 Q1 2.71M $9.09M -$2.66M $3.36 30
2021 Q4 3.31M $17.8M +$14.8M $5.37 35